SCHEMBL4245879

SCHEMBL4245879

Cc1ccc(Nc2ncc(Br)c(NC(C)CO)n2)cc1S(=O)(=O)NCCN1CCCC1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDR P35968 13/20 0.54
▸ CDK1 P06493 10/20 0.54
▸ CDK2 P24941 10/20 0.54
▸ CA2 P00918 3/20 0.54
▸ CDK4 P11802 3/20 0.54
▸ CDK7 P50613 3/20 0.54
▸ CDK9 P50750 3/20 0.54
▸ CCNT1 O60563 1/20 0.54
▸ CCND1 P24385 1/20 0.54
▸ CCNH P51946 1/20 0.54
▸ CCNB1 P14635 2/20 0.54
▸ CCNE1 P24864 2/20 0.54
▸ SRC P12931 5/20 0.44
▸ BRD4 O60885 4/20 0.43
▸ ABL1 P00519 2/20 0.43
▸ BMPR1B O00238 1/20 0.43
▸ PLK4 O00444 1/20 0.43
▸ STK25 O00506 1/20 0.43
▸ CIT O14578 1/20 0.43
▸ RIOK3 O14730 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4065978 1.00 KDR (0.54) KDRCDK1CDK2CA2CDK4
SCHEMBL4062490 0.99 KDR (0.54) KDRCDK1CDK2CA2CDK4
SCHEMBL4062724 0.93 KDR (0.52) KDRCDK1CDK2CA2CDK4
SCHEMBL4064797 0.91 BRD4 (0.44) KDRCDK1CDK2CA2CDK4
SCHEMBL4066724 0.90 BRD4 (0.44) KDRCDK1CDK2CA2CDK4
SCHEMBL4065573 0.88 CDK1 (0.66) KDRCDK1CDK2CA2CDK4
SCHEMBL4060897 0.87 CDK1 (0.65) KDRCDK1CDK2CA2CDK4
SCHEMBL4066641 0.87 KDR (0.60) KDRCDK1CDK2CA2CDK4
SCHEMBL4060664 0.86 KDR (0.50) KDRCDK1CDK2CA2CDK4
SCHEMBL4061605 0.86 KDR (0.50) KDRCDK1CDK2CA2CDK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1392662-B1 CDK INHIBITING PYRIMIDINES, PRODUCTION THEREOF AND THEIR USE AS MEDICAMENTS BAYER SCHERING PHARMA AG (DE) 2009-01-07 — — EP disclosed
Send feedback